BackCytoMed Therapeutics Overview

CytoMed Therapeutics Operating Income

Operating Income for GDTC.

Quarterly Operating Income

$-1832753.00
↑ 48.88% YoY

As of Dec 31, 2025

Annual Operating Income (TTM)

$-4057551.00
↓ 20.45% YoY

Trailing 12 months ending Dec 31, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin